Epigenetics Expert Appointed Director of Cincinnati Cancer Center
Shuk-Mei Ho, PhD, has been appointed director of the Cincinnati Cancer Center, effective June 15, 2013. The Cincinnati Cancer Center is a collaborative initiative of the University of Cincinnati, UC Health and Cincinnati Childrens Hospital Medical Center.
Ho is currently the Jacob G. Schmidlapp Chair of Environmental Health and Professor in the UC College of Medicine, a role she has held since October 2005 and will continue to fill. A recognized translational scientist, Ho is internationally known for her expertise in the role of hormones, endocrine disruptors and epigenetics in cancer development as well as gene-environment interaction cancer research.
"In addition to being a driven translational scientist, Shuk-Mei has been shown her skill as an administrative leader by aggressively growing an already successful academic department, bringing million in funds to UC, and creating research partnerships that bridge UC and Cincinnati Childrens, said Thomas Boat, MD, CCC Governing Board member and Christian R. Holmes Professor and Dean of the College of Medicine and Vice President for Health Affairs at University of Cincinnati.
Ho has recruited 21 environmental health faculty members since 2005many with a cancer research focusand secured more than $27 million for UC for research and infrastructure improvements.
The Cincinnati Cancer Center encompasses the activities of University of Cincinnati Cancer Instituteone of four institutes of UC and UC Healthand the Cancer and Blood Diseases Institute at Cincinnati Childrens.
"Weve established three initial programmatic research themes that will serve as the driving force for our work. Success of these initial programsas well as future programswill be determined by scientific excellence and emergence of productive collaborations among Cincinnati Cancer Center members, says Ho. "Im excited and honored to lead such a brilliant group of Cincinnati-based scientists as we work toward our ultimate aspiration of creating a world-class comprehensive center designated by the National Cancer Institute and leading in research innovation to eliminate cancer.
Hos appointment follows our recruitment last year of Vijaya Gandhi, PhD, MBA, as associate director for administration at the Cincinnati Cancer Center.
In Hos role as Cincinnati Cancer Center director, she will work closely with an administrative team and research program leaders to develop cross-institutional and cross-departmental research teams and to ensure alignment with the National Cancer Institutes guidelines for research programs and initiatives.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.